Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC. That opens the door for ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

The Food and Drug Administration (FDA) has approved Zepbound to help treat obstructive sleep apnea (OSA ... for certain people with obesity. Medicare Part D prescription drug plans may cover ...

Obstructive sleep apnea, or OSA ... for those with the condition on Medicare, which doesn't cover drugs solely for weight loss. Without insurance coverage, Zepbound costs $1,060 per month ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Be sure to ask your insurance company whether Zepbound requires prior authorization. Currently, Medicare does not provide coverage for Zepbound for weight loss or weight management uses.

The Centers for Medicare and Medicaid Services recently announced—without explanation—that it would not proceed with a proposal initiated by the Biden Administration to cover weight-loss drugs like ...

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and ...

Due to current legislation regarding weight loss drugs, Medicare Part D or Part C plans with drug coverage may only cover Zepbound for treating obstructive sleep apnea (OSA). However, the Centers ...